Stock Research: Evotec

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Evotec

XTRA:EVT DE0005664809
66
  • Value
    44
  • Growth
    85
  • Safety
    Safety
    80
  • Combined
    92
  • Sentiment
    22
  • 360° View
    360° View
    66
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Evotec SE is a drug discovery and development company. It operates in neuroscience, diabetes, oncology, infectious diseases, and respiratory diseases. Evotec SE operates in Germany. In the last fiscal year, the company had a market cap of $1,491 million, profits of $119 million, and revenue of $825 million, with 4827 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 66 (better than 66% compared with alternatives), overall professional sentiment and financial characteristics for the stock Evotec are above average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Evotec. The consolidated Value Rank has an attractive rank of 80, which means that the share price of Evotec is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 80% of alternative stocks in the same industry. The consolidated Growth Rank has a good rank of 85, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. But the professional market sentiment is below average compared with other stock investment alternatives with a Sentiment Rank of 22. Professional investors are more confident in 78% other stocks. Worryingly, the company has risky financing, with a Safety rank of 44. This means 56% of comparable companies have a safer financing structure than Evotec. ...read more

more
Index
CDAX
Moonshot Tech
MDAX
TecDAX
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 76 15 6
Growth
85 8 89 63
Safety
Safety
44 44 36 12
Sentiment
22 1 16 49
360° View
360° View
66 10 20 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
45 27 78 34
Opinions Change
76 57 21 50
Pro Holdings
n/a 19 14 58
Market Pulse
9 7 29 55
Sentiment
22 1 16 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
80 76 15 6
Growth
85 8 89 63
Safety Safety
44 44 36 12
Combined
92 39 42 8
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
1 1 6 1
Price vs. Earnings (P/E)
82 80 40 14
Price vs. Book (P/B)
90 82 41 45
Dividend Yield
1 1 1 1
Value
80 76 15 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
60 65 78 60
Profit Growth
89 10 92 98
Capital Growth
69 4 16 12
Stock Returns
73 10 86 70
Growth
85 8 89 63
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 36 40 15
Refinancing
75 77 67 40
Liquidity
4 18 23 23
Safety Safety
44 44 36 12

Similar Stocks

Discover high‑ranked alternatives to Evotec and broaden your portfolio horizons.

thyssenkrupp

XTRA:TKA
Country: Germany
Industry: Steel
Size: X-Large
Full Stock Analysis

KSB

XTRA:KSB
Country: Germany
Industry: Industrial Machinery
Size: Medium
Full Stock Analysis

Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.

BUSE:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Infineon

XTRA:IFX
Country: Germany
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.